Barthels M, Edel J, Liese B, Karges H E
Klin Wochenschr. 1982 Mar;60(6):303-9. doi: 10.1007/BF01716807.
Factor XII plasma levels were investigated with several methods in patients with hemophilia A and B and von Willebrand syndrome. There seem to be some families with hemophilia A or von Willebrand syndrome, who have an additional, congenital, partial lack of factor XII (Hageman factor). The mode of inheritance is independent of the other coagulation disorder. Frequently, the first indication of an additional factor XII deficiency is the disproportionate prolongation of the activated partial thromboplastin time (PTT) as regards the factor VIII level. The average factor XII level in patients with hemophilia A and von Willebrand syndrome is significantly lower than in normal subjects or patients with hemophilia B. It cannot be excluded that the frequently low levels of factor XII in patients with severe hemophilia are acquired and probably due to liver cell damage.
采用多种方法对甲型和乙型血友病患者以及血管性血友病综合征患者的血浆中凝血因子 XII 水平进行了研究。似乎有一些甲型血友病或血管性血友病综合征家族,其成员还存在先天性的部分凝血因子 XII(哈格曼因子)缺乏。其遗传方式与其他凝血障碍无关。通常,额外的凝血因子 XII 缺乏的首个迹象是活化部分凝血活酶时间(PTT)相对于因子 VIII 水平出现不成比例的延长。甲型血友病和血管性血友病综合征患者的凝血因子 XII 平均水平显著低于正常受试者或乙型血友病患者。不能排除重度血友病患者中凝血因子 XII 水平经常偏低是后天获得性的,且可能是由于肝细胞损伤所致。